The year 2021 will mark 100 years since the discovery of insulin. Insulin, the first medication
to be discovered for diabetes, is still the safest and most potent glucose-lowering therapy …

The global cost of diabetes care exceeds 1trillioneachyearwithmorethan 327 billion being
spent in the United States alone. Despite some of the advances in diabetes care including …

Objective To provide evidence-based recommendations regarding the use of advanced
technology in the management of persons with diabetes mellitus to clinicians, diabetes-care …

Aim Automated insulin delivery systems have improved glycaemic control in people with
type 1 diabetes mellitus. The analysis investigated predictors of improved sensor glucose …

• If unexplained hypoglycemia is frequent, evaluation for unrecognized celiac and Addison's
disease should be considered (E).• Currently available technologies like CGM, automated …

OBJECTIVE This study evaluated a new insulin delivery system designed to reduce insulin
delivery when trends in continuous glucose monitoring (CGM) glucose concentrations …

Insulin treatment that mimics normal physiological patterns as closely as possible remains
the cardinal principle of treatment for type 1 diabetes. Since the last guidelines were …

摘要监测总体血糖控制水平的金标准是HbA1c. 然而, HbA1c 有几个重要的局限性, 测量之前2‐3
月的血糖水平所影响的HbA1c 权重要大于短期血糖控制水平. 另外, HbA1c …

OBJECTIVE Short-term studies with automated systems that suspend basal insulin when
hypoglycemia is predicted have shown a reduction in hypoglycemia; however, efficacy and …

Background Hypoglycaemia unawareness and severe hypoglycaemia can increase fear of
hypoglycaemia and the risk of subsequent hypoglycaemic events. We aimed to assess the …